<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02902198</url>
  </required_header>
  <id_info>
    <org_study_id>fMRI Taste 2</org_study_id>
    <nct_id>NCT02902198</nct_id>
  </id_info>
  <brief_title>Taste Physiology in Obese Volunteers Before and After Bariatric Surgery</brief_title>
  <official_title>Taste Physiology in Obese Volunteers Before and After Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to investigate neuro-anatomical correlates of gastrointestinal taste
      stimulation by means of functional MRI before and after bariatric surgery. Intragastric
      administration of glucose, monosodium glutamate, chloroquine and placebo is followed by
      functional brain MRI in obese humans before and 3 months after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of tastants on cerebral blood flow measured by functional brain MRI</measure>
    <time_frame>changes from baseline to one hour after treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of tastants plasma glucagon-like peptide (GLP-1) concentrations</measure>
    <time_frame>changes from baseline to one hour after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of tastants plasma ghrelin concentrations</measure>
    <time_frame>changes from baseline to one hour after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Placebo preoperative</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single intragastric instillation of 200ml tap water via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo postoperative</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single intragastric instillation of 200ml tap water via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose preoperative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intragastric instillation of 200ml tap water with 25g glucose via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose postoperative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intragastric instillation of 200ml tap water with 25g glucose via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monosodium glutamate preoperative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intragastric instillation of 200ml tap water with 1g monosodium glutamate via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monosodium glutamate postoperative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intragastric instillation of 200ml tap water with 1g monosodium glutamate via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quinine preoperative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intragastric instillation of 200ml tap water with 17mg quinine via nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quinine postoperative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intragastric instillation of 200ml tap water with 17mg quinine via nasogastric tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Tap water 200ml</description>
    <arm_group_label>Placebo preoperative</arm_group_label>
    <arm_group_label>Placebo postoperative</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glucose</intervention_name>
    <description>25g Glucose in 200ml tap water</description>
    <arm_group_label>Glucose preoperative</arm_group_label>
    <arm_group_label>Glucose postoperative</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Monosodium glutamate</intervention_name>
    <description>1g monosodium glutamate in 200ml tap water</description>
    <arm_group_label>Monosodium glutamate preoperative</arm_group_label>
    <arm_group_label>Monosodium glutamate postoperative</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Quinine</intervention_name>
    <description>17mg quinine in 200ml tap water</description>
    <arm_group_label>Quinine preoperative</arm_group_label>
    <arm_group_label>Quinine postoperative</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  morbidly obese patients (BMI min 35kg/m2) scheduled for bariatric surgery

          -  right handed

        Exclusion Criteria:

          -  cardiovascular disease

          -  neurologic/psychiatric disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Beglinger, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>University Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bettina Wölnerhanssen, Dr</last_name>
    <email>bettina.woelnerhanssen@usb.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hopital Basel</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bettina Wölnerhanssen, Dr</last_name>
      <email>bettina.woelnerhanssen@usb.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2016</study_first_submitted>
  <study_first_submitted_qc>September 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2016</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Quinine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

